Epidemiologic and etiologic factors of pancreatic cancer
- PMID: 12063821
- DOI: 10.1016/s0889-8588(01)00003-x
Epidemiologic and etiologic factors of pancreatic cancer
Abstract
Ranking fourth as a cause of death from cancer for men and women in the United States, pancreatic cancer represents a significant challenge for physicians and surgeons. In addition to the elderly, high-risk groups include blacks, men, smokers, and patients with certain preexisting diseases such as pancreatitis and long-standing diabetes. Various inherited genetic disorders cause approximately 5% to 10% of the total cases of pancreatic cancer. Smoking doubles the risk of pancreatic cancer. Control of smoking offers the best available strategy for reducing the incidence of this disease. Dietary measures to reduce the risk of pancreatic cancer include maintenance of normal body weight and consumption of a well balanced diet with adequate amounts of fruits and vegetables. Chronic pancreatitis caused by heavy alcohol consumption or, rarely, by an underlying inherited disorder is another strong risk factor, but because this benign disease is uncommon, elimination of this underlying cause would have minimal impact on the frequency of pancreatic cancer.
Similar articles
-
Pancreatic cancer: a review of the evidence on causation.Clin Gastroenterol Hepatol. 2008 Mar;6(3):275-82. doi: 10.1016/j.cgh.2007.12.041. Clin Gastroenterol Hepatol. 2008. PMID: 18328435 Review.
-
[The epidemiology of pancreatic cancer].Orv Hetil. 2010 Oct 31;151(44):1816-22. doi: 10.1556/OH.2010.28986. Orv Hetil. 2010. PMID: 20961843 Review. Hungarian.
-
Epidemiology of pancreatic cancer.Minerva Chir. 2004 Apr;59(2):99-111. Minerva Chir. 2004. PMID: 15238885 Review.
-
Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):726-31. doi: 10.1158/1055-9965.EPI-05-0797. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16614115
-
Epidemiology of pancreatic cancer: an overview.Nat Rev Gastroenterol Hepatol. 2009 Dec;6(12):699-708. doi: 10.1038/nrgastro.2009.177. Epub 2009 Oct 6. Nat Rev Gastroenterol Hepatol. 2009. PMID: 19806144 Review.
Cited by
-
The association of new-onset diabetes with subsequent diagnosis of pancreatic cancer-novel use of a large administrative database.J Public Health (Oxf). 2023 Jun 14;45(2):e266-e274. doi: 10.1093/pubmed/fdac118. J Public Health (Oxf). 2023. PMID: 36321614 Free PMC article.
-
A novel scoring system to analyze combined effect of lifestyle factors on pancreatic cancer risk: a retrospective case-control study.Sci Rep. 2017 Oct 20;7(1):13657. doi: 10.1038/s41598-017-13182-w. Sci Rep. 2017. PMID: 29057932 Free PMC article.
-
Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy.Oxid Med Cell Longev. 2021 Oct 18;2021:3687700. doi: 10.1155/2021/3687700. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34707776 Free PMC article. Review.
-
Serum pepsinogen level, atrophic gastritis and the risk of incident pancreatic cancer--a prospective cohort study.Cancer Epidemiol. 2009 Nov;33(5):368-73. doi: 10.1016/j.canep.2009.09.001. Epub 2009 Oct 1. Cancer Epidemiol. 2009. PMID: 19800305 Free PMC article.
-
18F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer.World J Gastroenterol. 2011 Jan 14;17(2):231-5. doi: 10.3748/wjg.v17.i2.231. World J Gastroenterol. 2011. PMID: 21245997 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical